These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2064258)

  • 21. [Treatment of Behçet's disease with colchicine].
    Török L; Egyedi K
    Hautarzt; 1983 Feb; 34(2):87-8. PubMed ID: 6841085
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term efficacy and safety of infliximab in the treatment of Behçet's disease.
    Capella MJ; Foster CS
    Ocul Immunol Inflamm; 2012 Jun; 20(3):198-202. PubMed ID: 22486265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases].
    Fontes V; Machet L; Huttenberger B; Lorette G; Vaillant L
    Ann Dermatol Venereol; 2002 Dec; 129(12):1365-9. PubMed ID: 12536172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological features and visual prognosis of Behçet's disease.
    Ando K; Fujino Y; Hijikata K; Izawa Y; Masuda K
    Jpn J Ophthalmol; 1999; 43(4):312-7. PubMed ID: 10482479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behçet's disease. Apropos of 32 cases].
    Bitar E; Ghayad E; Ghoussoub K; Sinno W; Chams H; Khoury A; Baloglou P; Kallab K; Halaby C; Chemaly R
    Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):621-4. PubMed ID: 3616444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.
    Masuda K; Nakajima A; Urayama A; Nakae K; Kogure M; Inaba G
    Lancet; 1989 May; 1(8647):1093-6. PubMed ID: 2566048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of spermatogenesis in patients with Behçet's disease treated with cyclophosphamide and colchicine.
    Fukutani K; Ishida H; Shinohara M; Minowada S; Niijima T; Hijikata K; Izawa Y
    Fertil Steril; 1981 Jul; 36(1):76-80. PubMed ID: 6788612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial.
    Demiroglu H; Ozcebe OI; Barista I; Dündar S; Eldem B
    Lancet; 2000 Feb; 355(9204):605-9. PubMed ID: 10696980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major arterial involvement and review of Behcet's disease.
    Alpagut U; Ugurlucan M; Dayioglu E
    Ann Vasc Surg; 2007 Mar; 21(2):232-9. PubMed ID: 17349371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
    Hazen PG; Michel B
    Arch Dermatol; 1979 Nov; 115(11):1303-6. PubMed ID: 507883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of aphthosis with thalidomide and with colchicine].
    Genvo MF; Faure M; Thivolet J
    Dermatologica; 1984; 168(4):182-8. PubMed ID: 6724071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of colchicine in the treatment of Behçet's disease].
    Gasparini G; Sambvani N; Contini D; Brigonzi A
    G Ital Dermatol Venereol; 1985; 120(2):159-63. PubMed ID: 4007958
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytostatic and immunosuppressive treatment of ocular Behçet syndrome].
    Schilling H; Bornfeld N; Windeck R; Wessing A; Kirch W
    Klin Monbl Augenheilkd; 1990 Feb; 196(2):62-9. PubMed ID: 2325343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurological manifestations of Behçet's disease: evaluation of 40 patients treated by cyclophosphamide.
    Ait Ben Haddou EH; Imounan F; Regragui W; Mouti O; Benchakroune N; Abouqal R; Benomar A; Yahyaoui M
    Rev Neurol (Paris); 2012 Apr; 168(4):344-9. PubMed ID: 22136880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative study.
    Al-Waiz MM; Sharquie KE; A-Qaissi MH; Hayani RK
    Dermatol Online J; 2005 Dec; 11(3):3. PubMed ID: 16409899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic thrombocytopenic purpura in a patient with Behçet's disease.
    Jabr FI; Shamseddine A; Uthman I; Chehal A; Taher A
    Arthritis Rheum; 2003 May; 48(5):1468-9; author reply 1469. PubMed ID: 12746932
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Behçet's syndrome. Apropos of 12 cases].
    Ortega-Resinas M; Sánchez-Pedreño-Guillén P; Camacho-Martínez F
    Med Cutan Ibero Lat Am; 1982; 10(6):399-406. PubMed ID: 6192298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
    Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
    Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.